Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net loss	$ (66,221)	$ (48,625)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	5,137	3,328
Non-cash interest expense related to note payable	260
Stock-based compensation	4,551	2,516
Changes in current assets and liabilities:
Prepaid expenses and other assets	(410)	(2,595)
Right-of-use assets and lease liabilities, net	(2,047)	(9)
Accounts payable	528	10
Accrued expense and other liabilities	732	3,234
Deferred revenue	(9,033)	(6,536)
Net cash used in operating activities	(66,503)	(48,677)
Cash flows from investing activities:
Purchases of property and equipment	(4,225)	(9,941)
Net cash used in investing activities	(4,225)	(9,941)
Cash flows from financing activities:
Proceeds from issuance of convertible preferred stock, net of issuance costs		99,730
Proceeds from exercise of stock options	133	291
Issuance of common stock under ESPP plan	193
Proceeds from initial public offering, net of issuance costs		89,647
Proceeds from issuance of term loan, net of issuance costs paid to lender	29,354
Payments of debt issuance costs	(324)
Net cash provided by financing activities	29,356	189,668
Net (decrease) increase in cash, cash equivalents and restricted cash	(41,372)	131,050
Cash, cash equivalents, and restricted cash - beginning of period	166,436	35,386
Cash, cash equivalents, and restricted cash - end of period	125,064	166,436
Summary of cash, cash equivalents and restricted cash reported within the consolidated balance sheets:
Cash and cash equivalents	120,027	161,405
Restricted cash	5,037	5,031
Total cash, cash equivalents, and restricted cash	125,064	166,436
Supplemental disclosure of cash flow information:
Cash paid for interest	660
Supplemental disclosure of non-cash investing and financing activities:
Lease liability arising from obtaining right-of-use asset	53,541
Purchase of property and equipment in accounts payable and accrued liabilities	$ 444	828
Conversion of convertible preferred stock to common stock upon closing of initial public offering		$ 159,411